Incidence of HANA Conditions in HIV-infected Individuals

Launched by CHINESE UNIVERSITY OF HONG KONG · Mar 25, 2018

Keywords

ClinConnect Summary

This clinical trial is looking at how different treatments for HIV might affect the development of certain health conditions in people living with the virus. Specifically, it aims to understand the incidence of health issues like high blood pressure, diabetes, bone density problems, and liver health among newly diagnosed HIV patients in Hong Kong who are starting anti-retroviral therapy. The study will compare two types of treatment regimens to see if one is better than the other in preventing these conditions over time.

To be eligible for this trial, participants must be at least 40 years old, have a confirmed HIV infection, and have never received anti-retroviral treatment before. They will be monitored before starting treatment and again at 48 and 96 weeks after beginning their therapy. This study is important because it will help doctors understand how to better manage the long-term health of people living with HIV, especially as they live longer thanks to effective treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Confirmed HIV infection by HIV antibody or RNA test
• • 2. Age ≥40 years old
• • 3. Anti-retroviral treatment naïve
• • 4. Agree to initiate anti-retroviral therapy (ART) as determined by in-charge HIV physician
• Exclusion Criteria:
• • 1. Pregnancy
• • 2. Unable to give informed consent

Trial Officials